<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font23 { font-size : 23; } .font26 { font-size : 26; } .font27 { font-size : 27; } .font28 { font-size : 28; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">long-term </span>
   <span class="font28">OPV </span>
   <span class="font28">PID </span>
   <span class="font27">excretors </span>
   <span class="font26">poliovirus </span>
   <span class="font23">patients </span>
   <span class="font20">infection </span>
   <span class="font18">chronic </span>
   <span class="font17">VAPP </span>
   <span class="font17">[]. </span>
   <span class="font16">countries </span>
   <span class="font16">iVDPV </span>
   <span class="font16">CVID </span>
   <span class="font16">approximately </span>
   <span class="font16">prevalence </span>
   <span class="font16">excretion </span>
   <span class="font16">use </span>
   <span class="font15">model </span>
   <span class="font15">treatment </span>
   <span class="font15">prolonged </span>
   <span class="font15">polio </span>
   <span class="font14">cessation </span>
   <span class="font14">risk </span>
   <span class="font14">time </span>
   <span class="font14">death </span>
   <span class="font14">years </span>
   <span class="font14">(i.e., </span>
   <span class="font14">global </span>
   <span class="font14">income </span>
   <span class="font14">survival </span>
   <span class="font14">based </span>
   <span class="font14">identified </span>
   <span class="font14">PAVD </span>
   <span class="font14">individuals </span>
   <span class="font14">monthly </span>
   <span class="font13">clinical </span>
   <span class="font13">probability </span>
   <span class="font13">rates </span>
   <span class="font13">different </span>
   <span class="font13">{border-style </span>
   <span class="font13">Table </span>
   <span class="font13">patient </span>
   <span class="font13">population </span>
   <span class="font13">primary </span>
   <span class="font13">vaccine </span>
   <span class="font13">IVIG </span>
   <span class="font13">potential </span>
   <span class="font13">px;} </span>
   <span class="font13">represent </span>
   <span class="font13">screening </span>
   <span class="font13">treated </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">PIDs </span>
   <span class="font12">assume </span>
   <span class="font12">effectiveness </span>
   <span class="font12">excretor </span>
   <span class="font12">infections </span>
   <span class="font12">number </span>
   <span class="font12">onset </span>
   <span class="font12">probabilities </span>
   <span class="font12">rate </span>
   <span class="font12">data </span>
   <span class="font12">high-income </span>
   <span class="font12">iVDPVs </span>
   <span class="font12">infected </span>
   <span class="font12">known </span>
   <span class="font12">serotype </span>
   <span class="font12">antiviral </span>
   <span class="font12">asymptomatic </span>
   <span class="font12">developing </span>
   <span class="font12">estimated </span>
   <span class="font12">immunodeficiency </span>
   <span class="font12">infection, </span>
   <span class="font12">months </span>
   <span class="font12">vaccine-derived </span>
   <span class="font12">[], </span>
   <span class="font12">age </span>
   <span class="font12">excrete </span>
   <span class="font12">excretors, </span>
   <span class="font12">high </span>
   <span class="font12">immunity </span>
   <span class="font12">immunodeficient </span>
   <span class="font12">paralytic </span>
   <span class="font12">polioviruses </span>
   <span class="font12">reported </span>
   <span class="font12">studies </span>
   <span class="font12">transmission </span>
   <span class="font12">(Table </span>
   <span class="font12">Infect </span>
   <span class="font12">PAVDs </span>
   <span class="font12">current </span>
   <span class="font12">estimate </span>
   <span class="font12">level </span>
   <span class="font12">long </span>
   <span class="font12">middle-income </span>
   <span class="font12">people </span>
   <span class="font12">relatively </span>
   <span class="font12">results </span>
   <span class="font12">risks </span>
   <span class="font12">upper </span>
   <span class="font11">Clin </span>
   <span class="font11">analysis </span>
   <span class="font11">associated </span>
   <span class="font11">disease </span>
   <span class="font11">given </span>
   <span class="font11">low </span>
   <span class="font11">lower </span>
   <span class="font11">oPIDs </span>
   <span class="font11">proportion </span>
   <span class="font11">(Fig. </span>
   <span class="font11">Polio </span>
   <span class="font11">average </span>
   <span class="font11">bound </span>
   <span class="font11">drug </span>
   <span class="font11">evidence </span>
   <span class="font11">fraction </span>
   <span class="font11">limited </span>
   <span class="font11">month </span>
   <span class="font11">provide </span>
   <span class="font11">represents </span>
   <span class="font11">suggests </span>
   <span class="font11">(e.g., </span>
   <span class="font11">DES </span>
   <span class="font11">GPEI </span>
   <span class="font11">United </span>
   <span class="font11">assumed </span>
   <span class="font11">cessation, </span>
   <span class="font11">countries, </span>
   <span class="font11">develop </span>
   <span class="font11">development </span>
   <span class="font11">events </span>
   <span class="font11">impact </span>
   <span class="font11">include </span>
   <span class="font11">longer </span>
   <span class="font11">new </span>
   <span class="font11">oPID </span>
   <span class="font11">opportunities </span>
   <span class="font11">patients, </span>
   <span class="font11">period </span>
   <span class="font11">prior </span>
   <span class="font11">reduce </span>
   <span class="font11">research </span>
   <span class="font11">stages </span>
   <span class="font11">stop </span>
   <span class="font11">surviving </span>
   <span class="font11">total </span>
   <span class="font11">uncertainty </span>
   <span class="font11">vs. </span>
   <span class="font11">Fig. </span>
   <span class="font11">However, </span>
   <span class="font11">OPV-only </span>
   <span class="font11">World </span>
   <span class="font11">active </span>
   <span class="font11">cases </span>
   <span class="font11">deficiency </span>
   <span class="font11">diagnosed </span>
   <span class="font11">effective </span>
   <span class="font11">estimates </span>
   <span class="font11">excretion, </span>
   <span class="font11">excretors. </span>
   <span class="font11">important </span>
   <span class="font11">level, </span>
   <span class="font11">million </span>
   <span class="font11">poliomyelitis </span>
   <span class="font11">px; </span>
   <span class="font11">recovery </span>
   <span class="font11">serotypes </span>
   <span class="font11">stopped </span>
   <span class="font11">study </span>
   <span class="font11">type </span>
   <span class="font11">wild </span>
   <span class="font11">year </span>
   <span class="font11">{font-family </span>
   <span class="font11">(), </span>
   <span class="font11">Based </span>
   <span class="font11">Health </span>
   <span class="font11">IPV </span>
   <span class="font11">assuming </span>
   <span class="font11">available </span>
   <span class="font11">baseline </span>
   <span class="font11">combined </span>
   <span class="font11">common </span>
   <span class="font11">compared </span>
   <span class="font11">distribution </span>
   <span class="font11">exist </span>
   <span class="font11">font-size </span>
   <span class="font11">future </span>
   <span class="font11">higher </span>
   <span class="font11">incidence </span>
   <span class="font11">including </span>
   <span class="font11">increase </span>
   <span class="font11">modeling </span>
   <span class="font11">populations </span>
   <span class="font11">potentially </span>
   <span class="font11">relative </span>
   <span class="font11">remains </span>
   <span class="font11">small </span>
   <span class="font11">spontaneously </span>
   <span class="font11">values </span>
   <span class="font11">virus </span>
   <span class="font11">.Duintjer </span>
   <span class="font11">CVIDs </span>
   <span class="font11">DisSuppl </span>
   <span class="font11">Eradication </span>
   <span class="font11">Global </span>
   <span class="font11">IPV-only </span>
   <span class="font11">IPV/OPV </span>
   <span class="font11">Relative </span>
   <span class="font11">Serotype </span>
   <span class="font11">affect </span>
   <span class="font11">assumes </span>
   <span class="font11">continued </span>
   <span class="font11">detected </span>
   <span class="font11">determine </span>
   <span class="font11">developed </span>
   <span class="font11">diseases </span>
   <span class="font11">does </span>
   <span class="font11">double; </span>
   <span class="font11">duration </span>
   <span class="font11">excreting </span>
   <span class="font11">excretion. </span>
   <span class="font11">exposure </span>
   <span class="font11">general </span>
   <span class="font11">identify </span>
   <span class="font11">immunization </span>
   <span class="font11">immunocompetent </span>
   <span class="font11">infection. </span>
   <span class="font11">isolated </span>
   <span class="font11">lapse </span>
   <span class="font11">large </span>
   <span class="font11">lead </span>
   <span class="font11">management </span>
   <span class="font11">occur </span>
   <span class="font11">oral </span>
   <span class="font11">overall </span>
   <span class="font11">prevent </span>
   <span class="font11">provides </span>
   <span class="font11">questions </span>
   <span class="font11">secondary </span>
   <span class="font11">status </span>
   <span class="font11">surveillance </span>
   <span class="font11">variable </span>
   <span class="font10">(all </span>
   <span class="font10">.collab: </span>
   <span class="font10">Figure </span>
   <span class="font10">Given </span>
   <span class="font10">PAVDs, </span>
   <span class="font10">Thus, </span>
   <span class="font10">additional </span>
   <span class="font10">apparent </span>
   <span class="font10">better </span>
   <span class="font10">blocks </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">bounds </span>
   <span class="font10">cessation. </span>
   <span class="font10">clear </span>
   <span class="font10">compound </span>
   <span class="font10">drugs </span>
   <span class="font10">efforts </span>
   <span class="font10">environmental </span>
   <span class="font10">eradication </span>
   <span class="font10">follow-up </span>
   <span class="font10">help </span>
   <span class="font10">immune </span>
   <span class="font10">levels </span>
   <span class="font10">likely </span>
   <span class="font10">longitudinal </span>
   <span class="font10">model, </span>
   <span class="font10">person-years </span>
   <span class="font10">persons </span>
   <span class="font10">previously </span>
   <span class="font10">receive </span>
   <span class="font10">recover </span>
   <span class="font10">remain </span>
   <span class="font10">review </span>
   <span class="font10">screened </span>
   <span class="font10">serotypes, </span>
   <span class="font10">severe </span>
   <span class="font10">significant </span>
   <span class="font10">simulation </span>
   <span class="font10">solid; </span>
   <span class="font10">survival, </span>
   <span class="font10">therapy </span>
   <span class="font10">time, </span>
   <span class="font10">use, </span>
   <span class="font10">using </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Assumes </span>
   <span class="font10">Centers </span>
   <span class="font10">Chronic, </span>
   <span class="font10">January, </span>
   <span class="font10">Lower </span>
   <span class="font10">OPV? </span>
   <span class="font10">Oral </span>
   <span class="font10">Poliovirus </span>
   <span class="font10">Primary </span>
   <span class="font10">Prolonged, </span>
   <span class="font10">Research </span>
   <span class="font10">Sri </span>
   <span class="font10">Upper </span>
   <span class="font10">WPV </span>
   <span class="font10">ability </span>
   <span class="font10">absence </span>
   <span class="font10">accumulation </span>
   <span class="font10">addition, </span>
   <span class="font10">affected </span>
   <span class="font10">and/or </span>
   <span class="font10">annual </span>
   <span class="font10">appropriate </span>
   <span class="font10">birth </span>
   <span class="font10">births </span>
   <span class="font10">bold </span>
   <span class="font10">burn-in </span>
   <span class="font10">cVDPVs </span>
   <span class="font10">case </span>
   <span class="font10">category </span>
   <span class="font10">clearing </span>
   <span class="font10">contrast, </span>
   <span class="font10">courier; </span>
   <span class="font10">curves </span>
   <span class="font10">depends </span>
   <span class="font10">effectively </span>
   <span class="font10">em; </span>
   <span class="font10">experience </span>
   <span class="font10">fatal </span>
   <span class="font10">following </span>
   <span class="font10">fractions </span>
   <span class="font10">health </span>
   <span class="font10">high-income, </span>
   <span class="font10">identification </span>
   <span class="font10">imply </span>
   <span class="font10">inactivated </span>
   <span class="font10">includes </span>
   <span class="font10">increased </span>
   <span class="font10">indicate </span>
   <span class="font10">information </span>
   <span class="font10">insufficient </span>
   <span class="font10">live </span>
   <span class="font10">management. </span>
   <span class="font10">middle </span>
   <span class="font10">oPIDs, </span>
   <span class="font10">observed </span>
   <span class="font10">onset, </span>
   <span class="font10">paralysis </span>
   <span class="font10">policy </span>
   <span class="font10">pt;} </span>
   <span class="font10">quality </span>
   <span class="font10">recent </span>
   <span class="font10">reintroduction </span>
   <span class="font10">related </span>
   <span class="font10">replication </span>
   <span class="font10">respectively) </span>
   <span class="font10">role </span>
   <span class="font10">serotype-specific </span>
   <span class="font10">shows </span>
   <span class="font10">status, </span>
   <span class="font10">stochastic </span>
   <span class="font10">stratification </span>
   <span class="font10">sufficient </span>
   <span class="font10">symptoms </span>
   <span class="font10">true </span>
   <span class="font10">untreated </span>
   <span class="font10">vaccination </span>
  </p>
 </body>
</html>
